| Title : Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses - Kamal_2017_CNS.Neurol.Disord.Drug.Targets_16_820 |
| Author(s) : Kamal MA , Shakil S , Nawaz MS , Yu QS , Tweedie D , Tan Y , Qu X , Greig NH |
| Ref : CNS Neurol Disord Drug Targets , 16 :820 , 2017 |
| Abstract : Kamal_2017_CNS.Neurol.Disord.Drug.Targets_16_820 |
| ESTHER : Kamal_2017_CNS.Neurol.Disord.Drug.Targets_16_820 |
| PubMedSearch : Kamal_2017_CNS.Neurol.Disord.Drug.Targets_16_820 |
| PubMedID: 28176640 |
Kamal MA, Shakil S, Nawaz MS, Yu QS, Tweedie D, Tan Y, Qu X, Greig NH (2017)
Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses
CNS Neurol Disord Drug Targets
16 :820
Kamal MA, Shakil S, Nawaz MS, Yu QS, Tweedie D, Tan Y, Qu X, Greig NH (2017)
CNS Neurol Disord Drug Targets
16 :820